Suppression of REM rebound by Pergolide
- 1 June 1984
- journal article
- case report
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 59 (2) , 151-159
- https://doi.org/10.1007/bf01255413
Abstract
A 71 year old retired printer developed idiopathic Parkinson's disease over a period of 3 years. On account of his worsening condition he was admitted to hospital. Following the interruption of his medication the patient developed an akinetic crisis. A 48 hour polysomnogram recording, repeated five times during hospitalization, showed severe sleep deprivation. Treatment with Pergolide alone was then started; and sleep monitoring showed suppression of REM rebound, REM only appearing when the dose of the drug was reduced. It is suggested that REM rebound phenomena produced by sleep deprivation in a Parkinson's disease patient are suppressed by the effect of the dopaminergic agent Pergolide.Keywords
This publication has 21 references indexed in Scilit:
- Dopamine metabolism and receptor sensitivity in rat brain after REM sleep deprivationPharmacology Biochemistry and Behavior, 1983
- Opioid peptidesLife Sciences, 1980
- On the specificity of naloxone as an opiate antagonistLife Sciences, 1979
- Lergotrile and lisuride: In vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptorLife Sciences, 1978
- Overview of present day treatment of Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Effects of lisuride and LSD on cerebral monoamine systems and hallucinosisNature, 1978
- Effects of bromocriptine on central dopaminergic receptorsLife Sciences, 1976
- Double-Blind Controlled Study of L-Dopa Therapy in SchizophreniaPsychiatry and Clinical Neurosciences, 1975
- The behavioral effects of amphetamine on REM deprived ratsJournal of Psychiatric Research, 1969
- Biogenic Amines and the States of SleepScience, 1969